Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 10, 2024

Toripalimab Plus Chemotherapy as First-Line Therapy for Extensive-Stage SCLC

JAMA Oncology

 

Additional Info

JAMA Oncology
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial
JAMA Oncol 2024 Nov 14;[EPub Ahead of Print], Y Cheng, W Zhang, L Wu, C Zhou, D Wang, B Xia, M Bi, X Fu, C Li, D Lv, Y Zhao, G Chen, T Yi, J Huang, M Li, R Yang, X Huang, Y Wang, M Zhang, Y Pan, Y Sun, S Hu, X Zhang, M Zhou, J Fang, F Jin, Y Liu, Y Li, Z Zhang, J Hu, L Liu, R Wang, Y Li, K Gu, C Ding, Q Fan, G Zhang, Y Chen, L Jiang, WE Zheng, S Chen, C Huang, Z Han, H Yang, J Wang, B Wang, H Wu, Y Bao, M Li, X Luo, S Gu, W Yu, K Xu, S Zhang, J Yu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading